Global Mosquito-borne Infections Testing Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Test Type;

Molecular Diagnostics, Immunoassay Systems, ELISA, Rapid Tests, Blot Systems & Evaluation Software and Microspot Array Diagnostics.

By Indication;

Malaria, Zika Virus, Chikungunya, Dengue and Others.

By End Users;

Hospitals and Clinics, Private Commercial Laboratories, Academic & Research Centers and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn109164484 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Mosquito-borne Infections Testing Market (USD Million), 2021 - 2031

In the year 2024, the Global Mosquito-borne Infections Testing Market was valued at USD 25,675.34 million. The size of this market is expected to increase to USD 43,718.61 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.9%.

Mosquito-borne diseases encompass a range of illnesses caused by various pathogens, including bacteria, viruses, and parasites, which are transmitted to humans through the bites of infected mosquitoes and other blood-sucking insects like ticks. Among the most prevalent and emerging viral diseases spread by mosquitoes are Chikungunya, dengue fever, Japanese encephalitis, malaria, West Nile virus, yellow fever, and Zika virus. These diseases pose significant public health challenges globally, affecting millions of people each year and causing considerable morbidity and mortality in affected populations.

Mosquito-borne infections testing plays a crucial role in diagnosing these diseases and guiding appropriate treatment interventions. Testing kits designed for mosquito-borne infections enable healthcare providers to determine whether an individual is infected with a specific virus or pathogen. These kits utilize various diagnostic methods, including serological assays, molecular diagnostics, and rapid tests, to detect the presence of viral antigens, antibodies, or genetic material in patient samples. Typically, blood or urine samples are collected from patients suspected of having a mosquito-borne illness, and the testing kits are employed to identify the causative agent, aiding in timely diagnosis and patient management. By facilitating early detection and intervention, mosquito-borne infections testing kits contribute to the effective control and prevention of these diseases, thereby reducing their impact on public health and supporting efforts to mitigate outbreaks and transmission.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Test Type
    2. Market Snapshot, By Indication
    3. Market Snapshot, By End Users
    4. Market Snapshot, By Region
  4. Global Mosquito-borne Infections Testing Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Incidence of Mosquito-borne Infections
        2. Growing Awareness and Education
        3. Technological Advancements in Diagnostic Testing
        4. Government Initiatives and Funding
        5. Global Travel and Climate Change
      2. Restraints
        1. Limited Access to Healthcare
        2. High Cost of Testing
        3. Complexity of Disease Diagnosis
        4. Regulatory Challenges
        5. Emergence of Alternative Testing Methods
      3. Opportunities
        1. Focus on Point-of-Care Testing
        2. Expansion of Market in Emerging Economies
        3. Development of Multiplex Testing Platforms
        4. Strategic Partnerships and Collaborations
        5. Investment in Research and Development
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market SegmentationCompetitive Landscape
    1. Global Mosquito-borne Infections Testing Market, By Test Type, 2021 - 2031 (USD Million)
      1. Molecular Diagnostics
      2. Immunoassay Systems
      3. ELISA
      4. Rapid Tests
      5. Blot Systems & Evaluation Software
      6. Microspot Array Diagnostics
    2. Global Mosquito-borne Infections Testing Market, By Indication, 2021 - 2031 (USD Million)
      1. Malaria
      2. Zika Virus
      3. Chikungunya
      4. Dengue
      5. Others
    3. Global Mosquito-borne Infections Testing Market, By End Users, 2021 - 2031 (USD Million)
      1. Hospitals and Clinics
      2. Private Commercial Laboratories
      3. Academic & Research Centers
      4. Others
    4. Global Mosquito-borne Infections Testing Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. InBios International Inc
      2. NovaTec Immundiagnostica GmbH
      3. Abbott Laboratories
      4. Abnova Corporation
      5. Thermo Fisher Scientific Inc
      6. Certest Biotech SL
      7. F. Hoffmann-La Roche Ltd
      8. OriGene Technologies Inc
  7. Analyst Views
  8. Future Outlook of the Market